Latest In

News

What Drugs Should Not Be Taken With Benzonatate?

Understanding what drugs should not be taken with benzonatate is essential to ensure the safety and effectiveness of this medication.

Author:James Pierce
Reviewer:Karan Emery
Feb 23, 202418 Shares9.1K Views
Benzonatate is a widely prescribed medication known for its efficacy in alleviating cough symptoms. However, it is crucial to be mindful of potential interactions with other drugs, as certain combinations can lead to adverse effects. Understanding what drugs should not be taken with benzonatateis essential to ensure the safety and effectiveness of this medication.
In this article, we will explore the potential interactions that can arise when combining benzonatate with specific drugs, shedding light on the importance of informed and responsible medication use

How Benzonatate Works

Benzonatate is a non-narcotic antitussive medication used to relieve cough symptoms. Its mechanism of action involves its effects on the nervous system, particularly the cough reflex. Here's a breakdown of how benzonatate works:
  • Local Anesthetic Action - Benzonatate acts as a local anesthetic in the respiratory passages, primarily in the lungs and bronchi. It numbs or anesthetizes the stretch receptors located in the respiratory passages, which are responsible for triggering the cough reflex in response to irritation.
  • Suppression Of Cough Reflex - The cough reflex is a protective mechanism that helps clear the airways of irritants, mucus, or foreign particles. Benzonatate suppresses the cough reflex by inhibiting the signals transmitted by the stretch receptors. This results in a decreased urge to cough and provides relief from persistent or irritating coughing.
  • No Direct Action On Airways Or Mucus Production - Unlike expectorants or mucolytics that work by thinning and loosening mucus, benzonatate does not have a direct effect on airway secretions or mucus production. Instead, it primarily addresses the symptom of cough by reducing the sensitivity of the respiratory passages to irritants.
  • Limited Central Nervous System (CNS) Activity - Benzonatate has minimal penetration into the central nervous system, which means it has limited sedative or psychotropic effects. Unlike opioid-based cough suppressants, benzonatate is not associated with the risk of respiratory depression or addiction.
  • Duration Of Action - Benzonatate is known for its relatively long duration of action, providing cough relief for an extended period after administration. The sustained effect allows for less frequent dosing compared to some other cough medications.

Antihistamines

When benzonatate, a cough suppressant, is taken alongside certain antihistamines with sedative properties, such as diphenhydramine found in medications like Benadryl, the combined effect can intensify sedation and drowsiness. Sedative antihistamines are known to cause sleepiness by affecting the central nervous system, and when used concurrently with benzonatate, the overall drowsiness can be more pronounced. This increased sedation may contribute to a heightened sense of sleepiness and lethargy.
The enhanced sedative effects of combining benzonatate and sedating antihistamines can also impact cognitive function, leading to difficulties with concentration and alertness. Engaging in activities that require mental clarity, such as driving or operating machinery, should be approached with caution due to the potential for slowed reaction times. Patients need to be aware of the possibility of increased drowsiness and its impact on daily activities, and healthcare providers may consider recommending alternative non-sedating antihistamines to mitigate these effects.
A woman holding a capsule and glass of water
A woman holding a capsule and glass of water

Opioid Analgesics

When benzonatate is used in conjunction with opioid pain medications like codeine or hydrocodone, a significant interaction emerges with potential repercussions on the respiratory system. Both opioid analgesics and benzonatate possess the capacity to depress the central nervous system, including the respiratory centers in the brain. Several precautions need to be considered to manage this combination effectively.
One major concern involves the heightened risk of respiratory depression when opioids and benzonatate are combined. Respiratory depression entails a reduction in both the rate and depth of breathing, and each of these medications can individually contribute to this effect by suppressing the respiratory drive in the brain. When utilized concurrently, their impact on the respiratory system becomes additive, elevating the potential for severe respiratory depression. This risk is particularly alarming for individuals with pre-existing respiratory conditions or compromised lung function.
Another cautionary aspect involves the potential decrease in breathing function resulting from the combined action of benzonatate and opioids. This diminished ability of the brain to regulate breathing appropriately poses particular concerns, emphasizing the importance of careful monitoring by healthcare providers. Additionally, the combination may lead to increased sedation, adding an extra layer of caution.

Central Nervous System (CNS) Depressants

When benzonatate is combined with other medications that depress the central nervous system (CNS), like benzodiazepines (for example, alprazolam and diazepam) or barbiturates, there is a potential for an intensification of sedative effects. This interaction is noteworthy due to its impact on the overall functioning of the CNS and can result in heightened side effects that affect an individual's daily activities and coordination.
Benzonatate's ability to enhance sedative effects means that when taken in conjunction with CNS depressants, the combined impact may lead to increased drowsiness. This heightened drowsiness can be more pronounced than when each medication is taken separately, making individuals feel excessively sleepy or fatigued. Moreover, the combination may contribute to an elevated sense of dizziness, affecting balance and making activities such as walking or standing more challenging.
The potential for impaired coordination is another concern when combining benzonatate with CNS depressants. Both medication types can individually induce coordination difficulties, and their synergistic effect can exacerbate this impairment. Individuals may experience challenges in maintaining balance and performing tasks that require precise motor skills. Considering the risks associated with the combination, caution is advised, and individuals are encouraged to refrain from activities that demand high levels of coordination and attention while using these medications concurrently.

Tricyclic Antidepressants

When benzonatate is taken alongside tricyclic antidepressants such as amitriptyline or imipramine, there is a potential for an augmentation of sedative effects. This interaction is significant as it can intensify the drowsiness caused by both medications, potentially affecting an individual's ability to stay awake and attentive. Understanding the implications of combining these substances is crucial for individuals and healthcare providers alike.
Tricyclic antidepressants, known for their sedative properties, work on the central nervous system. When used concurrently with benzonatate, which also has mild sedative effects, the overall impact on the CNS can be heightened. This increased sedation may lead to a more pronounced sense of drowsiness, making it important for individuals to be aware of the potential for enhanced fatigue and the need to exercise caution in activities that require mental alertness.
In addition to increased drowsiness, the combination of tricyclic antidepressants and benzonatate may result in impaired cognitive function. This means that tasks requiring clear thinking, concentration, and quick decision-making could be compromised. Individuals taking this combination of medications should be mindful of potential cognitive effects and, when necessary, seek guidance from healthcare providers to adjust dosages or explore alternative treatments that minimize these risks.

Monoamine Oxidase Inhibitors (MAOIs)

When benzonatate is combined with Monoamine Oxidase Inhibitors (MAOIs) like phenelzine or tranylcypromine, there is a potential for a serious interaction that can lead to increased side effects. This interaction is particularly concerning due to the risk of a hypertensive crisis, which is characterized by a severe and sudden increase in blood pressure. Understanding the nature of this interaction is crucial for both individuals and healthcare providers to ensure the safe use of these medications.
MAOIs function by inhibiting the activity of the enzyme monoamine oxidase, which plays a role in the breakdown of neurotransmitters in the brain. When combined with benzonatate, the potential for increased side effects arises. Of utmost concern is the risk of a hypertensive crisis, where blood pressure can surge to dangerously high levels. This condition poses significant health risks, especially for individuals with pre-existing cardiovascular conditions, and necessitates immediate medical attention.
A woman that has cough and flu
A woman that has cough and flu

Sedating Antihypertensive Medications

When benzonatate is combined with certain antihypertensive medications, especially those known for their sedative effects, there is a potential for additive effects. This interaction is noteworthy as it may intensify the sedation caused by both medications, impacting an individual's alertness and cognitive function. Understanding the implications of combining benzonatate with sedating antihypertensive medications is essential for both individuals and healthcare providers.
Antihypertensive medications, such as clonidine or guanfacine, are prescribed to lower blood pressure. When used alongside benzonatate, which can induce mild sedation, the combined effect on the central nervous system can be heightened. The potential for additive sedative effects may lead to increased drowsiness, requiring individuals to exercise caution in situations that demand mental alertness, such as driving or operating machinery.

What Drugs Should Not Be Taken With Benzonatate? - FAQ

Is Benzonatate Bad For Your Heart?

Important warningsThis may cause spasms of your bronchi (the main passageway into your throat and airways) and vocal cords. It may also cause negative effects on your heart and blood vessels. Psychiatric problems: This drug may cause confusion and visual hallucinations (seeing something that isn't there).

Does Benzonatate Increase Blood Pressure?

But sucking, chewing, breaking, or crushing benzonatate oral capsules can cause serious side effects. These include very low blood pressure and sudden impaired or abnormal heart function. For this reason, it's important that you always swallow benzonatate capsules whole.

What To Avoid When Taking Benzonatate?

Do not take this medication with any of the following: MAOIs like Carbex, Eldepryl, Marplan, Nardil, and Parnate.

Final Thoughts

While benzonatate proves to be a valuable remedy for cough relief, it is imperative to be aware of its potential interactions with other medications. By understanding what drugs should not be taken with benzonatate, individuals can make informed decisions about their healthcare.
Always consult with a healthcare professional before combining medications, and be proactive in providing your medical history to ensure a comprehensive assessment of potential drug interactions. Prioritizing safety and informed decision-making is paramount for achieving the maximum benefits of benzonatate without compromising overall health.
Jump to
James Pierce

James Pierce

Author
Karan Emery

Karan Emery

Reviewer
Latest Articles
Popular Articles